On this basis, Tuttolomondo et al. conducted a study [22] with the aim to evaluate plasma levels of adiponectin, resistin, and IL-6 in subjects with diabetic foot in comparison with subjects without foot complications. This evidence concerns the gene IL6 and diabetic foot.